The TCS PIONEER Series is a curated IP training programme for innovators, entrepreneurs, and business leaders, offering practical insights into intellectual property strategy and commercialization. The seminar provides participants with practical training in key aspects of patent practice and strategy. Topics include identifying common patenting pitfalls, drafting strong patent specifications and claims, conducting prior art searches and patentability assessments, understanding freedom-to-operate considerations, and developing effective global filing strategies. Through interactive sessions that combine foundational principles with practical exercises and case studies, Jennifer and Pauli share their experience in international patent practice to help participants strengthen their understanding of patent law and innovation protection.

We are thrilled to be part of this initiative and look forward to the remaining sessions covering patent drafting and prosecution, prior art and freedom-to-operate analyses, and strategic filing and global patent protection.

Learn more about the programme: 🔗 TCS PIONEER Series Details

我们的过去活动

Recommended Insights

When Standards Evolve: How China Judges Inventiveness in Next-Gen Tech Patents

2025年9月30日
Starting in 2023, Datang Mobile, one of the key players in China’s telecom standardization efforts, initiated infringement proceedings against Samsung in China, Germany, and the US. Samsung responded by filing multiple invalidation petitions in several jurisdictions, including China, the United States, and Europe. The case discussed below is one of above-mentioned invalidation cases in China, […]

China Releases Draft Examination Guidelines for the new Patent Law

2020年12月4日
The Chinese Patent Office (CNIPA) is moving forward at breakneck speeds aiming to get all the necessary pieces in place for the June 1, 2021 date when the new 4th Amendment of the Patent Law will come into effect. Most recently, this means a flurry of drafts coming out from CNIPA, including, but not limited […]

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

2021年5月24日
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

AI, Big Data, and Blockchain - CNIPA seeks public comment on draft patent examination guidelines

2019年11月21日
Exciting new changes continue to happen with the Chinese Patent Office (CNIPA). On November 12, 2019, the CNIPA published a new set of amendments to Part II Chapter 9 of the Patent Examination Guidelines (“Draft”) and requested public comment by December 11, 2019. In summary, the new guidelines clarify how emerging technologies involving artificial intelligence, […]
Top crossarrow-right